283 related articles for article (PubMed ID: 18316599)
1. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
Bemis LT; Chen R; Amato CM; Classen EH; Robinson SE; Coffey DG; Erickson PF; Shellman YG; Robinson WA
Cancer Res; 2008 Mar; 68(5):1362-8. PubMed ID: 18316599
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-25 functions in regulation of pigmentation by targeting the transcription factor MITF in Alpaca (Lama pacos) skin melanocytes.
Zhu Z; He J; Jia X; Jiang J; Bai R; Yu X; Lv L; Fan R; He X; Geng J; You R; Dong Y; Qiao D; Lee KB; Smith GW; Dong C
Domest Anim Endocrinol; 2010 Apr; 38(3):200-9. PubMed ID: 20036482
[TBL] [Abstract][Full Text] [Related]
3. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
4. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-dependent regulation of cKit in cutaneous melanoma.
Igoucheva O; Alexeev V
Biochem Biophys Res Commun; 2009 Feb; 379(3):790-4. PubMed ID: 19126397
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
7. Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.
Ugurel S; Houben R; Schrama D; Voigt H; Zapatka M; Schadendorf D; Bröcker EB; Becker JC
Clin Cancer Res; 2007 Nov; 13(21):6344-50. PubMed ID: 17975146
[TBL] [Abstract][Full Text] [Related]
8. Novel MITF targets identified using a two-step DNA microarray strategy.
Hoek KS; Schlegel NC; Eichhoff OM; Widmer DS; Praetorius C; Einarsson SO; Valgeirsdottir S; Bergsteinsdottir K; Schepsky A; Dummer R; Steingrimsson E
Pigment Cell Melanoma Res; 2008 Dec; 21(6):665-76. PubMed ID: 19067971
[TBL] [Abstract][Full Text] [Related]
9. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
Primot A; Mogha A; Corre S; Roberts K; Debbache J; Adamski H; Dreno B; Khammari A; Lesimple T; Mereau A; Goding CR; Galibert MD
Pigment Cell Melanoma Res; 2010 Feb; 23(1):93-102. PubMed ID: 19895547
[TBL] [Abstract][Full Text] [Related]
10. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
11. Expression of micro-RNA-145 is regulated by a highly conserved genomic sequence 3' to the pre-miR.
La Rocca G; Shi B; Sepp-Lorenzino L; Baserga R
J Cell Physiol; 2011 Mar; 226(3):602-7. PubMed ID: 20717966
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.
Kido K; Sumimoto H; Asada S; Okada SM; Yaguchi T; Kawamura N; Miyagishi M; Saida T; Kawakami Y
Cancer Sci; 2009 Oct; 100(10):1863-9. PubMed ID: 19659611
[TBL] [Abstract][Full Text] [Related]
13. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
15. The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis.
Larribere L; Hilmi C; Khaled M; Gaggioli C; Bille K; Auberger P; Ortonne JP; Ballotti R; Bertolotto C
Genes Dev; 2005 Sep; 19(17):1980-5. PubMed ID: 16140982
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP).
Goswami S; Tarapore RS; Poenitzsch Strong AM; TeSlaa JJ; Grinblat Y; Setaluri V; Spiegelman VS
J Biol Chem; 2015 Jan; 290(1):384-95. PubMed ID: 25414259
[TBL] [Abstract][Full Text] [Related]
17. Induction of microphthalmia transcription factor (Mitf) by forskolin and stimulation of melanin release in UISO-Mel-6 cells.
Lekmine F; Salti GI
J Surg Res; 2008 Sep; 149(1):27-30. PubMed ID: 18028952
[TBL] [Abstract][Full Text] [Related]
18. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
[TBL] [Abstract][Full Text] [Related]
19. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
20. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.
Selzer E; Wacheck V; Lucas T; Heere-Ress E; Wu M; Weilbaecher KN; Schlegel W; Valent P; Wrba F; Pehamberger H; Fisher D; Jansen B
Cancer Res; 2002 Apr; 62(7):2098-103. PubMed ID: 11929831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
